Abraham Silji
SEC CIK 1733001 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WST | West Pharmaceutical Services | SVP, CTO | 3,318 | — | $11.66M | 15 | 2022-02-22 | 2024-10-29 |
Most active insiders at WST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Favorite Annette F | SVP, Chief HR Off | — | $6.30M |
| 2 | Winters Chad | VP, CAO | — | $269.4K |
| 3 | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | — | — |
| 4 | Campbell Shane Alden | SVP, Proprietary Segment | — | — |
| 5 | Lockhart Stephen H | Dir | — | — |
| 6 | Witherspoon Charles | VP, Treas | — | — |
| 7 | Joseph Molly | Dir | — | — |
| 8 | McMahon Robert W. | SVP, CFO | — | — |
| 9 | Feehery William F | Dir | — | — |
| 10 | Pucci Paolo | Dir | — | — |
Abraham Silji made no open-market trades at WST in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-31 | 2024-10-29 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | M - OptEx | $0.00 | +458.02 | 3,318 | +16% | $0 |
| D | 2024-10-31 | 2024-10-29 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | F - Tax | $318.41 | -180.23 | 3,138 | -5% | -$57.4K |
| 2024-06-13 | 2024-06-12 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | S - Sale | $330.78 | -1,800 | 2,860 | -39% | -$595.4K | |
| D | 2024-02-27 | 2024-02-23 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | M - OptEx | $173.22 | +7,012 | 11.7K | +150% | +$1.21M |
| D | 2024-02-27 | 2024-02-23 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | S - Sale+OE | $365.00 | -7,012 | 4,660 | -60% | -$2.56M |
| D | 2024-02-22 | 2024-02-20 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | A - Grant | $0.00 | +646 | 4,660 | +16% | $0 |
| DM | 2023-08-10 | 2023-08-08 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | S - Sale+OE | $397.18 | -8,160 | 4,215 | -66% | -$3.24M |
| D | 2023-08-10 | 2023-08-08 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | M - OptEx | $102.51 | +8,160 | 12.4K | +194% | +$836.5K |
| DM | 2023-05-02 | 2023-05-01 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | S - Sale+OE | $365.60 | -8,020 | 4,858 | -62% | -$2.93M |
| D | 2023-05-02 | 2023-05-01 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | M - OptEx | $86.24 | +8,020 | 12.2K | +191% | +$691.6K |
| 2023-03-22 | 2023-03-01 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | A - Grant | $318.28 | +234 | 5,709 | +4% | +$74.5K | |
| 2023-03-22 | 2023-03-09 | WST | West Pharmaceutical Services | Abraham Silji | SVP, CTO | S - Sale | $322.57 | -1,500 | 4,209 | -26% | -$483.9K | |
| D | 2023-02-23 | 2023-02-21 | WST | West Pharmaceutical Services | Abraham Silji | Chief Digital, Trans Off | A - Grant | $306.68 | +2,274 | 5,475 | +71% | +$697.4K |
| 2022-08-03 | 2022-08-01 | WST | West Pharmaceutical Services | Abraham Silji | Chief Digital, Trans Off | S - Sale | $343.93 | -5,374 | 3,201 | -63% | -$1.85M | |
| 2022-02-24 | 2022-02-22 | WST | West Pharmaceutical Services | Abraham Silji | Chief Digital, Trans Off | A - Grant | $369.13 | +2,498 | 8,575 | +41% | +$922.1K |
Purchase Sale Sale after option exercise All abbreviations